Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-12
2005-04-12
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S512000, C548S516000, C549S059000, C549S462000
Reexamination Certificate
active
06878738
ABSTRACT:
The present invention relates to compounds of the formula Iin which one of the radicals R8 and R9 is a hydrogen atom or an alkyl group and the other is hydroxyl, alkoxy or acyloxy or where R8 and R9, together with the carbon atom to which they are bonded, are a carbonyl group and the radicals R1 to R7 have the meanings indicated in the description.The compounds inhibit the release of various mediators of the arachidonic acid cascade and can thus be used for the prevention of allergically induced disorders or for the treatment of disorders of the rheumatic type.
REFERENCES:
patent: 3705905 (1972-12-01), Culvenor et al.
patent: 4546100 (1985-10-01), Fabre et al.
patent: 4684658 (1987-08-01), Fabre et al.
patent: 5260451 (1993-11-01), Dannhardt et al.
patent: 198 45 446 (2000-04-01), None
patent: 9532970 (1995-12-01), None
patent: 9532971 (1995-12-01), None
patent: 95 32972 (1995-12-01), None
Gerd Dannhardt et al.: “Oxidative ringoeffnung von 6.7-Diphenyl-2.3-dihydro-1H-pyrrolizin (DADHP) durch m-chlorperbenzoesaeure” Arch. Pharm., vol. 319, pp. 231-234, 1986.
Gerd Dannhardt et al.: “Natriummetaperiodat-oxidation von 6.7-Diphenyl-2.3-dihydro-1H-pyrrolzin” Arch. Pharm., vol. 318, pp. 661-663, 1985.
Gerd Dannhardt et al.: “6.8-Diaryl-2.3-dihydro-1H-pyrrolizine (DADHP) als singulett-sauerstoff-faenger” Arch. Pharm., vol. 318, pp. 663-664, 1985.
Gerd Dannhardt et al.: Synthese und oxidation von 6.7-diphenyl-2.3-dihydro-1H-pyrrolizin-5-yl-acetaldehyd (DADHP-5-acetaldehyd) Arch. Pharm., vol. 319, pp. 500-505, 1986.
Gerd Dannhardt et al.: “6.7-diarylsubstituierte 1- und 3-pyrrolizinone (1-DAPON und 3-DAPON)” Arch. Pharm., vol. 319, pp. 749-755, 1986.
G. Dannhardt et al.: “C-5 functionalized 6,7-diphenyl-2,3-dihydro-1H-pyrrolizines as inhibitors of bovine cyclooxygenase and 5-lipoxygenase” Arch. Pharm., vol. 327, pp. 509-514, 1994.
Stefan Laufer et al.: “Synthesis and evaluation of a novel series of pyrrolizine derivatives as dual cyclooxygense-1 and 5-lipoxygenase inhibitors” Arch. Pharm. Pharm. Med. Chem., vol. 330, pp. 307-312, 1997.
Joseph M. Muchowski et al.: “Synthesis and anti-inflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrol[1,2-a]pyrrole-1-carboxyoic acids. The 6-substituted compounds” J. Med. Chem., vol. 30, pp. 820-823, 1987.
Stefan A. Laufer et al.: “(6,7-diaryldihydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase” J. Med. Chem., vol. 37, pp. 1894-1897, 1994.
“Antiinflammatory cyclooxygenase and 5-lipoxygenase inhibitor” Drugs of the Future, vol. 20, No. 10, pp. 1007-1007, 1995.
Gerd Dannhardt et al.: “Synthese und eigenschaften von 2,3-dihydro-1H-pyrrolizinen” Arch. Pharm., vol. 312, pp. 896-905, 1979.
Gerd Dannhardt et al.: “Stellungsisomere diaryldihydropyrrolizinyl-essigsaeuren und -hydroxethyl-derivate” Arch. Pharm. vol. 321, pp. 159-162, 1988.
Laufer Stefan
Striegel Hans-Guenter
Tollmann Karola
McKane Joseph K.
Merckle GmbH
Shameem Golam M M
LandOfFree
Anti-inflammatory oxo derivatives and hydroxy derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory oxo derivatives and hydroxy derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory oxo derivatives and hydroxy derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3368061